SAN FRANCISCO, Jan. 9, 2020 (DRUG TARGET REVIEW) – Modern day oncology therapies have seen significant innovation in the last decade. It is high time we commit to using biomarkers that are [...]
SAN FRANCISCO, Jan. 6, 2020 (SCRIP) – Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making [...]
SAN FRANCISCO, Dec. 2, 2019 (GENENGNEWS) – Machine learning, says Cofactor Genomics, moves RNA-seq to RNA models, enables multidimensional biomarkers.
SAN FRANCISCO, Nov. 4, 2019 (FIERCEPHARMA) – Are more drugs really the answer to unlocking precision medicine? New focus that prioritizes patient profiling is likely to have major impact.
Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform
— Announces “Functional to FFPE” Early-Access Grant Program — San Francisco — November 6, 2019 (REPORTABLE) — Cofactor Genomics, leaders in RNA-based technologies and [...]
SAN FRANCISCO, Oct. 10, 2019 (CIOREVIEW) – Drug developers and clinicians are looking for a biomarker that can capture more of a patient’s immunological profile, their response to [...]
San Francisco, September 27, 2019 (REPORTABLE) — Today Cofactor Genomics announced that it has expanded the leadership team with the promotion of Natalie LaFranzo, PhD to Vice President of [...]
Steven Daniel joins Cofactor Genomics as Vice President of Business Development — Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market — San [...]
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery — Contributing to both the Cancer and [...]